The growth of the Lhon Treatment Market is primarily driven by advancements in mitochondrial disease therapeutics Improved genetic screening now allows earlier diagnosis, while ongoing pipeline developments aim to restore mitochondrial function and halt optic nerve degeneration. https://www.databridgemarketresearch.com/